SCHEMBL10135385

SCHEMBL10135385

Cc1cc2oc3cc(O)c(C)c(O)c3c2c(=O)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.54
PTGS1 P23219 3/20 0.50
PTGS2 P35354 3/20 0.50
KDM4E B2RXH2 3/20 0.49
ABCB1 P08183 1/20 0.48
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ANTXR2 P58335 1/20 0.46
NUAK1 O60285 2/20 0.45
IGF1R P08069 2/20 0.45
PIM1 P11309 2/20 0.45
SRC P12931 2/20 0.45
KDR P35968 2/20 0.45
PLK1 P53350 2/20 0.45
PKN1 Q16512 2/20 0.45
AURKB Q96GD4 2/20 0.45
ALK Q9UM73 2/20 0.45
MET P08581 1/20 0.45
AXL P30530 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10135387 0.88 KDM4E (0.50) MAOAPTGS1PTGS2KDM4EABCB1
SCHEMBL10181447 0.88 PTGS1 (0.65) MAOAPTGS1PTGS2KDM4EABCB1
SCHEMBL10182556 0.87 NUAK1 (0.56) MAOAPTGS1PTGS2KDM4EABCB1
SCHEMBL10135383 0.81 KDM4E (0.52) MAOAPTGS1PTGS2KDM4EMAPT
SCHEMBL580570 0.81 PTGS1 (0.51) MAOAPTGS1PTGS2KDM4EMAPT
Eugenitol SCHEMBL29881346 0.79 PTGS1 (0.77) MAOAPTGS1PTGS2KDM4EABCB1
SCHEMBL10181747 0.78 MGAM (0.57) MAOAPTGS1PTGS2KDM4EMAPT
SCHEMBL10181886 0.78 PTGS1 (0.49) MAOAPTGS1PTGS2KDM4EMAPT
SCHEMBL10135392 0.78 KDM4E (0.46) MAOAPTGS1PTGS2KDM4EMAPT
SCHEMBL580862 0.78 KDM4E (0.64) MAOAPTGS1PTGS2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859235-B2 Methods in cell cultures, and related inventions, employing certain additives BASF SE (DE) 2014-10-14 US disclosed
US-8383088-B2 Coumestan-like antioxidants and UV absorbants BASF SE (DE) 2013-02-26 US disclosed
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BASF SE (DE) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164162-A1 METHODS IN CELL CULTURES, AND RELATED INVENTIONS, EMPLOYING CERTAIN ADDITIVES BBOX1, NEFM, NQO1 MAOA 113/4885PTGS1 554/4885PTGS2 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.